The Lancet HIV in conversation with

Mansoor Farahani, Wafaa El-Sadr, and Wilford Kirungi on the progress in the HIV response in Uganda

Richard Wu on a phase 1 trial of a broadly neutralising antibody for HIV

Grace Lui and Vincent Wong on lifestyle modifications to address MASLD in people with HIV

Debra ten Brink and Rowan Martin-Hughes on the effects of international aid cuts on HIV acquisitions and mortality

Sari Reisner on the benefits of gender-affirming hormone therapy on HIV clinical outcomes

Lisa Noguchi and Nyaradzo Mgodi on HIV prophylactic dapivirine ring in breastfeeding women

Sharon Lewin on requirements of a cell- and gene-based therapy product for HIV cure

Claudia Cortes y Giovanni Ravasi sobre VIH y migración (in Spanish)

Florence Riako Anam and Bruce Richman on U=U

Peter Hayward on 10 years of The Lancet HIV

Salome Kuchukidze and Souleymane Diabaté on the link between intimate partner violence and vertical HIV transmission in sub-Saharan Africa

José M. Zuniga on the future of urban HIV responses Commission

Alejandro García sobre los tiempos de transición en la atención médica continuada del VIH en España (ES)

Serge Eholie on treatments for HIV-2

Drew Voetsch and Robert Selato on achieving the 95-95-95 UNAIDS goals in Botswana

Adam Trickey on trends in causes of death among people with HIV in Europe and North America

Manik Kohli, Iain Reeves, and Laura Waters on homophobia in the provision of sexual health care in the UK

Lulu Nair, Connie Celum, and Kenneth Ngure on dapivirine vaginal ring and daily oral PrEP for HIV prevention in women

Sophia Rein on HIV treatment with INSTIs and cardiovascular events

Lawrence Mbuagbaw on reporting of HIV drug resistance in clinical studies using the CEDRIC-HIV checklist

Andreas Jahn and Nellie Wadonda-Kabondo on trends in HIV prevalence and incidence

Eryn Braley and Mckenzie Braley on experiences of HIV among global Indigenous populations

Ricardo Luque and Miguel Barriga on HIV prevalence and care continuum among migrants from Venezuela in Colombia (en Español)

Denton Callander on the effects of treatment as prevention

Andrea Wirtz and Sari Reisner on HIV incidence and mortality among transgender women

Yasmin Mohamed on early infant diagnosis of HIV

Salome Kuchukhidze and Francisco Mbofana on intimate partner violence and women with HIV

Lise Jamieson and Gesine Mayer-Rath on cabotegravir for PrEP in South Africa

Helen Ayles and Musonda Simwinge on the PopART trial

Carol Strong and Stephane Ku on HIV and chemsex

Elijah Kakande and Gabriel Chamie on TB interventions for people with HIV

Amir Mohareb on PrEP and hepatitis B

Kenneth Ngure on PrEP in Kenya

Marta Vasylyev and Casper Rokx on HIV care for displaced Ukranians

Angela Colbers and Hylke Waalewijn on treatment for children with HIV

Nabila El-Bassel on intimate partner violence and HIV

Amy Justice on ageing with HIV

Bridget Mugisa on the epidemiology of HIV in the Middle East and north Africa

Aaloke Mody and Izukanji Sikazwe on universal HIV treatment in Zambia

José Miro and Juliana Reyes on COVID-19 in people living with HIV

Jon Shuter on smokers with HIV

Elizabeth Marie King on menopausal hormone therapy

John Frater on COVID-19 vaccination and HIV

Elias Dah on PrEP in west Africa

Fatima Mir on the 2019 HIV outbreak in Pakistan

Jessica Castilho and Claudia Cortes on HIV life expectancy in Latin America and the Caribbean

Chloe Orkin on long-acting cabotegravir

Sarah Calabrese on U=U

Le Minh Giang and Todd Korthuis on opioid use disorder and HIV in Vietnam

Michael Herce, Tonia Poteat, Ward van Bilsen and Hanne Zimmerman, and Jade Pagkas-Bather